Substitutive dispensing to grant for drugs proven of bio-equivalency.
Published: 2001-11-12 06:59:00
Updated: 2001-11-12 06:59:00
The KFDA intends to ask the MOHW to allow pharmacies for the substitutive dispensing without physician's prior agreement when dispensing drugs proven of its bio-equivalency for the purpose of promoting their bio-equivalency test projects.
The KFDA surveyed drug manufacturers and the test insti...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
